Akoya Biosciences, Inc.
AKYA · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $69 | $113 | $135 | $109 |
| - Cash | $20 | $12 | $13 | $9 |
| + Debt | $84 | $84 | $85 | $85 |
| Enterprise Value | $132 | $186 | $207 | $185 |
| Revenue | $17 | $21 | $19 | $23 |
| % Growth | -22% | 13.4% | -18.8% | – |
| Gross Profit | $10 | $14 | $12 | $13 |
| % Margin | 59.3% | 67.4% | 62.3% | 57.8% |
| EBITDA | -$11 | -$4 | -$6 | -$9 |
| % Margin | -68% | -17.7% | -32.1% | -37% |
| Net Income | -$16 | -$8 | -$11 | -$13 |
| % Margin | -94.1% | -38.4% | -56% | -56.8% |
| EPS Diluted | -0.32 | -0.17 | -0.21 | -0.27 |
| % Growth | -88.2% | 19% | 22.2% | – |
| Operating Cash Flow | -$7 | -$3 | -$9 | -$11 |
| Capital Expenditures | -$0 | -$1 | -$0 | -$0 |
| Free Cash Flow | -$7 | -$4 | -$10 | -$11 |